Newrotex
PrivateLast Round
Grant
Jan 1, 2024
Total Funding Raised
$6.03M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Newrotex operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Grant round in January 2024.
Newrotex is a surgical devices company that develops silk-based medical solutions for peripheral nerve repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Newrotex Comparables
Compare Newrotex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNerve Limited | 83% | |
| Axonova Medical | 81% | |
| Auxilium Biotechnologies | 78% |
For institutional investors. Book with your work email.
Newrotex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2024 | ||||
| Accelerator | Oct 11, 2023 | ||||
| Grant | Mar 22, 2023 | ||||
| Grant | Aug 1, 2022 | ||||
| Grant | May 1, 2020 | ||||
Grant | May 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Newrotex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Horizon Europe Guarantee | Grant |
| MedTech Innovator | Accelerator |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 100% MoM, reaching 3.1K.
- Apr 17, 2026
Monthly visitors grew 210% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Newrotex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Newrotex's valuation, stock price, and market status.
Is Newrotex a public or private company?
Newrotex is a private company.
What is the current stock price of Newrotex?
Newrotex is a private company, so its shares have no public market price. Caplight tracks Newrotex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Newrotex worth (valuation)?
Valuation information for Newrotex is not publicly available.
Can I buy Newrotex stock?
Newrotex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Newrotex's last funding round?
Newrotex's most recent funding round was Grant on January 1, 2024.
Who are the main investors in Newrotex?
Key investors in Newrotex include European Innovation Council Fund, Horizon Europe Guarantee, Innovate UK.
Will Newrotex IPO soon?
No public IPO plans have been announced for Newrotex.
How can I track Newrotex secondary market activity?
Caplight tracks bids, offers, and trades in Newrotex's shares on secondary markets.